Tillman Gerngross project out of Dartmouth College acquired by Repligen
Hot off of his biotech unicorn landing on the Nasdaq, another project from the lab of Dartmouth College engineering professor Tillman Gerngross has made news, as it’s been acquired by Repligen.
Avitide will now be owned by Repligen, the company announced last Thursday, in a move made to boost its proteins business.
The deal moves Repligen into the world of affinity resin purification for gene therapy, and complements an established partnership with Navigo GmbH, the company said in the press release. Avitide develops purification technology for programs ranging from preclinical to commercial products. Earlier this month, Navio and Repligen collaborated to develop a ligand that helps overcome challenges associated with the purification of pH sensitive antibodies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.